Skip to main content
OpenTrials

Clinical trial condition

Urothelial Carcinoma (UC)

Explore clinical trials studying Urothelial Carcinoma (UC). Study availability and eligibility vary by location and protocol.

24 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Urothelial Carcinoma (UC) trial results

Recruiting

A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors

NCT07518043

Conditions
Carcinoma, Carcinoma, Transitional Cell, Esophageal and/or Cardia Cancer, +14 more
Locations
  • Fujian Medical University Union Hospital Fuzhou, China
  • The First Affiliated Hospital Zhejiang University School Of Medicine Hangzhou, China
  • The First Affiliated Hospital of Henan University of Science & Technology Luoyang, China
  • The Second Hospital of Tianjin Medical University Tianjin, China
View Trial Details
Recruiting

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

NCT07277413

Conditions
Adenocarcinoma Of Esophagus, Adenocarcinoma of Esophagus, Adenoma, +55 more
Locations
  • Providence Medical Foundation Santa Rosa, California, United States
  • Johns Hopkins Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • BRCR Global-Coral Springs Coral Springs, Florida, United States
  • Sarah Cannon Research Institute at Florida Cancer Specialists Orlando, Florida, United States
View all 16 locations
View Trial Details
Recruiting

Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer

NCT07673016

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +21 more
Locations
  • Urology San Diego Oceanside, California, United States
  • Genesis Research, LLC San Diego, California, United States
  • Urology Associates of Silicon Valley San Jose, California, United States
  • UroPartners, LLC Chicago, Illinois, United States
View all 23 locations
View Trial Details
Recruiting

Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

NCT05176483

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +47 more
Locations
  • Exelixis Clinical Site #67 Phoenix, Arizona, United States
  • Exelixis Clinical Site #1 Tucson, Arizona, United States
  • Exelixis Clinical Site #123 Palo Alto, California, United States
  • Exelixis Clinical Site #59 Santa Barbara, California, United States
View all 122 locations
View Trial Details

Related conditions